Purchase Order 75N93024P00513
- Not listed
- Pacific Biosciences of California, Inc. was awarded a $119,127 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. This multiple delivery order contract, set aside for total small businesses, will provide PacBio kits and reagents to support genomic research initiatives through September 2021. The original solicitation requested brand name only PacBio reagents to fulfill sequencing...
- This federal contract award from the National Institute of Allergy and Infectious Diseases to Pacific Biosciences of California, Inc. is for the provision of Pacific Bioscience Kits and Reagents. The $15,095.50 firm fixed-price purchase order does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) sequencing technology, which is utilized by various federal agencies to support genomic research...
- This federal contract award is for the delivery of PACBIO REAGENT KITS, including all reagents for sequencing 24 REVIO SMRT cells (quantity 8) and associated library prep reagents. The contract was awarded to Pacific Biosciences of California, Inc., a for-profit biotechnology company specializing in advanced DNA and RNA sequencing technologies. The contract has a ceiling value of $232,853.76 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of September 30, 2026. The...
- This $274,176 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Pacific Biosciences of California, Inc., a for-profit manufacturer. The contract is for the delivery of PacBio Revio sequencing reagents, which support the agency's genomic research initiatives. Pacific Biosciences is the original equipment manufacturer for the proprietary PacBio Sequel and Sequel II DNA/RNA sequencing...
- This IDIQ (Indefinite Delivery, Indefinite Quantity) contract award to Pacific Biosciences of California, Inc. is for the provision of sequencing reagents, kits, and consumables to the U.S. Department of Health and Human Services, Food and Drug Administration. The $95,554.00 award has a firm fixed price, with a completion date of October 18, 2021. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services associated with their Sequel and Sequel II DNA/RNA...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID) to Pacific Biosciences of California, Inc., a for-profit manufacturer of genomic sequencing equipment and consumables. The $363,000.00 firm-fixed-price purchase order is for the provision of a Sequel Instrument, which is part of Pacific Biosciences' proprietary single molecule, real-time (SMRT) sequencing technology. This award was not set aside for any specific business type. Pacific...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) awarded a purchase order to Pacific Biosciences of California, Inc. to procure specialized reagents for the PacBio Sequel sequencing platform. The $101,845.19 firm fixed-price contract provides the NIAID's Virus Persistence and Dynamics Section with the necessary reagents, such as sequencing kits, binding kits, and consumables, to conduct genomic research on...
- This firm-fixed-price purchase order for $32,500.00 was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Pacific Biosciences of California, Inc. to provide their Sequel and Sequel II DNA/RNA sequencing systems, reagent kits, consumables, and preventative maintenance services. This contract is not designated as a set-aside. Pacific Biosciences is a manufacturer of specialized scientific equipment and a major provider of sequencing...
- This federal contract award was made by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment, reagents, and services for DNA/RNA sequencing systems. The $158,720.18 purchase order is for the addition of items from Requisition #1199385, with a completion date of October 30, 2018. This contract is a firm-fixed price award and was set aside for small businesses. Pacific Biosciences has...
- This federal contract award is to Pacific Biosciences of California, Inc., a small business manufacturer of high-throughput, long-read DNA sequencing systems and associated consumables. The $22,845.96 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health, for the delivery of their Sequel and Sequel II sequencing platforms and related products. Pacific Biosciences holds two significant Indefinite...
This federal contract award is for the provision of Pacific Biosciences' proprietary reagent kits to support genomic research initiatives at the National Institute of Allergy and Infectious Diseases, which is part of the Department of Health and Human Services. The $11,864.64 firm fixed price purchase order has a completion date of July 3, 2024 and was awarded on April 4, 2024 to Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment, reagents, and services associated with their Sequel and Sequel II DNA/RNA sequencing systems. This contract is not set aside and is part of Pacific Biosciences' broader portfolio of over $10 million in federal contracts and delivery orders with agencies such as the Department of Agriculture, Food and Drug Administration, Centers for Disease Control, and Department of Defense to provide sequencing instruments, consumables, and associated services to support government genomic research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 4/3/24 |